2024-12-04 Hesai Technology HaiPress
PALO ALTO,Calif.,Dec. 2,2024 --Hesai (Nasdaq: HSAI),the global leader in lidar technology for robotics and industrial applications,autonomous driving,and ADAS,announced today that it will be exhibiting at Consumer Electronics Show (CES) 2025 in Las Vegas from January 7-10 (LVCC West Hall #6824). As of Q3 2024,Hesai has delivered over 600,000 units cumulatively to customers worldwide and continues to expand its lidar model offerings for automotive,robotic and industrial applications.
Hesai will premiere its newest model,a mini high-performance 3D lidar,during a press conference at CES on January 7 at 11:00 a.m. The presentation will provide detailed insights and live demonstrations showcasing the capabilities of the new lidar in robotic and industrial applications.
The new lidar combines high resolution and low power consumption in a compact,lightweight design. No larger than a billiard ball,it also offers extremely simple integration,making it ideal for machines where space is a premium,including AGVs and AMRs,delivery robots,autonomous lawnmowers,agricultural machinery and stationary applications.
"We continuously strive to push the boundaries with our product developments,and our new mini 3D lidar model exemplifies that approach," says David Li,CEO of Hesai. "It's a very valuable addition to our portfolio and we look forward to demonstrating its powerful capabilities,alongside our advanced automotive and autonomous mobility lidar models,at CES in January."
Celebrating its 10th anniversary,Hesai has established a strong presence globally,serving customers located in over 40 countries. With an operational footprint in Europe,the US and Asia,and more than 1,700 patents deployed,the company will continue to invest in its resources and technical developments,leveraging advanced technology to shape the future of mobility.
Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share
Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion
LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025
2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing
©copyright 2009-2020 Diet Tips Daily